Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 2352361, 6 pages
http://dx.doi.org/10.1155/2016/2352361
Research Article

Markers of Antioxidant Defense in Patients with Type 2 Diabetes

1Department of Diagnostics, Chair of Clinical Biochemistry, Jagiellonian University Medical College, 31-501 Krakow, Poland
2Department of Medical Diagnostics, Jagiellonian University Medical College, 30-688 Krakow, Poland
3Chair of Metabolic Diseases, Jagiellonian University Medical College, 31-501 Krakow, Poland

Received 28 April 2015; Accepted 14 June 2015

Academic Editor: Umesh Yadav

Copyright © 2016 K. Gawlik et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Giacco and M. Brownlee, “Oxidative stress and diabetic complications,” Circulation Research, vol. 107, no. 9, pp. 1058–1070, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. J. F. Turrens, “Mitochondrial formation of reactive oxygen species,” The Journal of Physiology, vol. 552, no. 2, pp. 335–344, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Ding, A. Kantarci, H. Hasturk, P. C. Trackman, A. Malabanan, and T. E. van Dyke, “Activation of RAGE induces elevated O2 generation by mononuclear phagocytes in diabetes,” Journal of Leukocyte Biology, vol. 81, no. 2, pp. 520–527, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Negre-Salvayre, R. Salvayre, N. Augé, R. Pamplona, and M. Portero-Otín, “Hyperglycemia and glycation in diabetic complications,” Antioxidants and Redox Signaling, vol. 11, no. 12, pp. 3071–3109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Čolak, V. Dimitrijević-Srećkovic, P. B. Djordjević et al., “Biomarkers of enzymatic and non-enzymatic antioxidative defense in type 2 diabetes mellitus—comparative analysis,” Biochemia Medica, vol. 18, no. 1, pp. 42–51, 2008. View at Google Scholar · View at Scopus
  6. S. A. Moussa, “Oxidative stress in diabetes mellitus,” Romanian Journal of Biophysics, vol. 18, no. 3, pp. 225–236, 2008. View at Google Scholar
  7. W. C. Stadie, “A method for the determination of methemoglobin in whole blood,” The Journal of Biological Chemistry, vol. 41, pp. 237–241, 1920. View at Google Scholar
  8. E. Beutler, O. Duron, and B. M. Kelly, “Improved method for the determination of blood glutathione,” The Journal of Laboratory and Clinical Medicine, vol. 61, no. 5, pp. 882–888, 1963. View at Google Scholar · View at Scopus
  9. D. E. Paglia and W. N. Valentine, “Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase,” The Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158–169, 1967. View at Google Scholar · View at Scopus
  10. D. M. Goldberg and R. J. Spooner, “Glutathione reductase,” in Methods in Enzymology, vol. 3, pp. 258–265, Chemie, Basel, Switzerland, 1983. View at Google Scholar
  11. I. F. F. Benzie and J. J. Strain, “The ferric reducing ability of plasma (FRAP) as a measure of ‘antioxidant power’: the FRAP assay,” Analytical Biochemistry, vol. 239, no. 1, pp. 70–76, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. “Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę,” Diabetologia Kliniczna, vol. 1, supplement A, 2012.
  13. M. Kumawat, N. Singh, and S. Singh, “Status of antioxidant enzymes and lipid peroxidation in type 2 diabetes mellitus with neuropathy,” Annals of Neurosciences, vol. 12, pp. 49–52, 2005. View at Google Scholar
  14. C. Kornhauser, J. R. Garcia-Ramirez, K. Wrobel, E.-L. Pérez-Luque, M.-E. Garay-Sevilla, and K. Wrobel, “Serum selenium and glutathione peroxidase concentrations in type 2 diabetes mellitus patients,” Primary Care Diabetes, vol. 2, no. 2, pp. 81–85, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. E. Rahbani-Nobar, A. Rahimi-Pour, and M. Rahbani-Nobar, “Total antioxidant capacity, superoxide dismutase and glutathione peroxidase in diabetic patients,” Medical Journal of Islamic Academy of Sciences, vol. 12, no. 4, pp. 109–114, 1999. View at Google Scholar
  16. J. Aaseth and G. Stoe-Birketvedt, “Trace elements in human health and diseases: an update glutathione in overweight patients with poorly controlled diabetes type 2,” The Journal of Trace Elements in Experimental Medicine, vol. 13, pp. 105–111, 2000. View at Google Scholar
  17. C. Livingstone and J. Davis, “Review: targeting therapeutics against glutathione depletion in diabetes and its complications,” British Journal of Diabetes and Vascular Disease, vol. 7, no. 6, pp. 258–265, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Ghayour-Mobarhan, A. Taylor, S. Lanham-New et al., “Serum selenium and glutathione peroxidase in patients with obesity and metabolic syndrome,” Pakistan Journal of Nutrition, vol. 7, no. 1, pp. 112–117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. L.-Y. Chen, W.-H. Zhu, Z.-W. Chen et al., “Relationship between hyperuricemia and metabolic syndrome,” Journal of Zhejiang University Science B, vol. 8, no. 8, pp. 593–598, 2007. View at Google Scholar · View at Scopus
  20. P. Hovind, P. Rossing, L. Tarnow, R. J. Johnson, and H.-H. Parving, “Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes—an inception cohort study,” Diabetes, vol. 58, no. 7, pp. 1668–1671, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Bonakdaran, M. Hami, and M. T. Shakeri, “Hyperuricemia and albuminuria in patients with type 2 diabetes mellitus,” Iranian Journal of Kidney Diseases, vol. 5, no. 1, pp. 21–24, 2011. View at Google Scholar · View at Scopus
  22. J.-S. Lim, D.-H. Lee, J.-Y. Park, S.-H. Jin, and D. R. Jacobs Jr., “A strong interaction between serum γ-glutamyltransferase and obesity on the risk of prevalent type 2 diabetes: results from the third national health and nutrition examination survey,” Clinical Chemistry, vol. 53, no. 6, pp. 1092–1098, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Neri, S. S. Signorelli, B. Torrisi et al., “Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls,” Clinical Therapeutics, vol. 27, no. 11, pp. 1764–1773, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Montonen, P. Knekt, R. Järvinen, and A. Reunanen, “Dietary antioxidant intake and risk of type 2 diabetes,” Diabetes Care, vol. 27, no. 2, pp. 362–366, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. A.-H. Harding, N. J. Wareham, S. A. Bingham et al., “Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of Cancer-Norfolk prospective study,” Archives of Internal Medicine, vol. 168, no. 14, pp. 1493–1499, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Czernichow, A. Couthouis, S. Bertrais et al., “Antioxidant supplementation does not affect fasting plasma glucose in the supplementation with antioxidant vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations,” The American Journal of Clinical Nutrition, vol. 84, no. 2, pp. 395–399, 2006. View at Google Scholar · View at Scopus
  27. C. Gökkuşu, Ş. Palanduz, E. Ademoğlu, and S. Tamer, “Oxidant and antioxidant systems in niddm patients: influence of vitamin E supplementation,” Endocrine Research, vol. 27, no. 3, pp. 377–386, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Paolisso, A. D'Amore, D. Galzerano et al., “Daily vitamin E supplements improve metabolic control but not insulin secretion in elderly type II diabetic patients,” Diabetes Care, vol. 16, no. 11, pp. 1433–1437, 1993. View at Publisher · View at Google Scholar · View at Scopus
  29. J. L. Ble-Castillo, E. Carmona-Díaz, J. D. Méndez et al., “Effect of α-tocopherol on the metabolic control and oxidative stress in female type 2 diabetics,” Biomedicine and Pharmacotherapy, vol. 59, no. 6, pp. 290–295, 2005. View at Publisher · View at Google Scholar · View at Scopus